Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian Cancer
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as cyclophosphamide, carboplatin, and
mitoxantrone, work in different ways to stop the growth of tumor cells, either by killing the
cells or by stopping them from dividing. Giving chemotherapy with autologous bone marrow
transplant may allow the doctor to give higher doses of chemotherapy and kill more tumor
cells.
PURPOSE: This phase II trial is studying how well chemotherapy and autologous bone marrow
transplant work in treating patients with refractory or recurrent ovarian cancer.